Pre-application Webinar for Metabolic Dysregulation and Cancer Risk Program: a Transdisciplinary Approach to Obesity-Associated Research - RFA-CA-21-021 and RFA-CA-21-022
Notice Number:
NOT-CA-21-094

Key Dates

Release Date:

July 7, 2021

Related Announcements

RFA-CA-21-021 - Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)
RFA-CA-21-022 - Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: a Transdisciplinary Approach to Obesity-Associated Research (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The NCI will hold a pre-application webinar on August 11, 2021, from 1:00 - 2:00 PM (ET) for the Funding Opportunity Announcements (FOA) RFA-CA-21-021 and RFA-CA-21-022 entitled " Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)" and Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed), respectively.

NCI staff members involved in these FOAs will provide orientation and technical assistance to potential applicants to the above-referenced FOAs by explaining the goals and objectives for the proposed FOAs and answer questions from webinar attendees.

Potential applicants are encouraged to submit questions when registered to the pre-application webinar or send questions to [email protected] by 12:00 PM ET on August 1st, 2021.

Webinar Information:

To join the Webinar, pre-registration is required through Webex.

To register for the August 11, 2021, webinar, please go to:

https://cbiit.webex.com/cbiit/onstage/g.php?MTID=e7d57e60342b6398dd616bdae002acbb7

Specific webinar information will be provided upon registration.

Participation in this webinar, although highly encouraged, is optional and is not required for the submission of an application in response to RFA-CA-21-021 and RFA-CA-21-022, respectively.

The webinar will be recorded for those who are not able to participate in the live event. A document highlighting frequently asked questions and corresponding answers will be posted, along with the webinar recording, to the following website approximately 2-3 weeks after the webinar: at https://epi.grants.cancer.gov/metabolic-dysregulation.

Inquiries

Please direct all inquiries to:

Tram Kim Lam, PhD, MPH
Division of Cancer Control and Population Sciences
National Cancer Institute (NCI)
Telephone: 240-276-6967
Email: [email protected]

For inquiries related to cancer biology:

Phillip J. Dashner, MSc
Division of Cancer Biology
National Cancer Institute (NCI)
Telephone: 240-276-6227
Email: [email protected]

For inquiries related to cancer prevention:

Edward R. Sauter, MD, PhD
Division of Cancer Prevention
National Cancer Institute (NCI)
Telephone: 240-276-7657
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices